Search results
Earnings call: Vistagen highlights progress in social anxiety treatment By Investing.com
Investing.com· 1 day agoVistagen Therapeutics (VTGN) has reported encouraging developments in its latest earnings call,...
The Potential Benefits and Dangers of Rewiring the Brain
Mercola· 5 days agoThe panel includes neuroscientists Takao Hensch and John Krakauer, as well as entrepreneur Brett Wingeier, co-founder and CEO of Magnus Medical. This capacity could potentially heal depression ...
Martha's Vineyard is about to run out of pot. That's led to a lawsuit and a scramble by regulators
The Bismarck Tribune· 3 hours agoMartha's Vineyard is about to run out of pot. One dispensary is already out entirely and the other...
Rutherrin(R) Increases Efficacy of Chemotherapy
The Joplin Globe· 1 day agoChemotherapy is currently one...
Scientists pinpoint likely origin of stuttering in the brain
LiveScience· 7 days agoThe brain imaging results were described in a recent paper, published May 27 in the journal Brain. Knowing what causes stuttering could aid the
FDA panel endorses approval of Alzheimer’s drug shown to slow progression of disease
KIRO 7 Seattle-Tacoma· 2 days agoA panel of independent advisors to the U.S. Food and Drug Administration has recommended an...
Lilly Alzheimer's drug gets unanimous backing from FDA advisory panel
New Hampshire Union Leader· 3 days agoOutside advisers to the Food and Drug Administration on Monday voted unanimously that the benefits...
Another psychedelic mushroom sold in gummies could be deadly
United Press International via Yahoo News· 21 hours agoGrowing public fascination with "magic" psilocybin mushrooms as a trendy treatment for depression...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers - UPI.com
UPI· 1 hour agoA study of more than 700 patients treated at Stanford University found that the risk of secondary...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 6 days agoThere...the document. Among the key safety considerations, the FDA said in its report, are...